🇺🇸 DEXFENFLURAMINE HYDROCHLORIDE in United States

12 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pulmonary Arterial Hypertension — 2 reports (16.67%)
  2. Pulmonary Hypertension — 2 reports (16.67%)
  3. Adrenal Neoplasm — 1 report (8.33%)
  4. Aortic Valve Calcification — 1 report (8.33%)
  5. Aortic Valve Incompetence — 1 report (8.33%)
  6. Aortic Valve Stenosis — 1 report (8.33%)
  7. Breast Cancer Female — 1 report (8.33%)
  8. Diarrhoea — 1 report (8.33%)
  9. Duodenal Ulcer Perforation — 1 report (8.33%)
  10. Dyspnoea — 1 report (8.33%)

Source database →

DEXFENFLURAMINE HYDROCHLORIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is DEXFENFLURAMINE HYDROCHLORIDE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for DEXFENFLURAMINE HYDROCHLORIDE in United States?

Marketing authorisation holder not available in our data.